TIAA Trust, National Association’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-4,282
Closed -$286K 661
2024
Q3
$286K Sell
4,282
-55
-1% -$5.05K ﹤0.01% 543
2024
Q2
$515K Sell
4,337
-118
-3% -$14.9K ﹤0.01% 422
2024
Q1
$475K Sell
4,455
-36
-0.8% -$3.63K ﹤0.01% 440
2023
Q4
$447K Buy
4,491
+102
+2% +$8.58K ﹤0.01% 435
2023
Q3
$453K Buy
+4,389
New +$490K ﹤0.01% 423

Other funds holding MRNA

TIAA Trust, National Association's MRNA Position: Q4 2024 in Review

TIAA Trust, National Association sold out of Moderna (MRNA) in Q4 2024, closing a stake of 4,282 shares — an estimated $286K sold.

TIAA Trust, National Association first reported a position in MRNA in Q3 2023 and held it in 5 quarters. The position peaked at $515K in Q2 2024. 745 funds tracked by Wall St. Rank hold MRNA as of Q4 2024.

  • TIAA Trust, National Association reported no remaining Moderna position as of Q4 2024 after selling out during the quarter.
  • TIAA Trust, National Association sold 4,282 Moderna shares in Q4 2024, an estimated $286K.
  • TIAA Trust, National Association first reported a position in Moderna in Q3 2023 and held it in 5 quarters.
  • TIAA Trust, National Association's Moderna position peaked at $515K in Q2 2024.
  • 745 funds tracked by Wall St. Rank held Moderna as of Q4 2024.

Based on TIAA Trust, National Association's 13F filing for Q4 2024, filed 11 Feb 2025.